Clemente-Tomás CP1* and Moreno-Sanz L2
1Department of Gynecology and Obstetrics, Doctor Peset University Hospital, Valencia, Spain
2Department of Gynecology and Obstetrics, Obispo Polanco Hospital, Teruel, Spain
*Corresponding Author: Clemente-Tomás CP, Department of Gynecology and Obstetrics, Doctor Peset University Hospital, Valencia, Spain.
Received: June 16, 2023; Published: July 10, 2023
Objective: We compare the levels of IL-6 in the AF of pregnant women with cervical shortening versus women with normal cervical length subjected to amniocentesis for other prenatal reasons (fetal malformations or high risk in prenatal screening), with the aim of establishing a cut-off point to facilitate prediction of the outcome of pregnancy.
Material and Methods: A descriptive case-control study design was applied to subjects (n=40) with available information on the results of amniotic fluid IL-6 levels. We examined perinatal outcomes.
The study comprised 40 women: 6 cases with cervical shortening (15%) and 34 controls with normal cervical length throughout pregnancy (85%). The mean IL-6 concentration among the cases was 758.83 pg/ml versus 1291.53 pg/ml in the control group, which moreover registered the highest concentration (16,383 pg/ml). The mean gestational age at delivery was 33 ± 6 weeks among the cases and 40 ± 3 weeks in the control group.
Results: Our results do not indicate that the determination of IL-6 in AF is useful for the diagnosis of subclinical chorioamnionitis as a possible cause of cervical shortening and consequent PB, since the controls with normal cervical length and full-term delivery showed higher concentrations than the women with cervical shortening.
Conclusion: Our findings do not suggest the determination of IL-6 in AF to be useful for the early diagnosis of such disorders and thus for the prevention of PB.
Keywords: Preterm Birth; Interleukin-6; Amniotic Fluid; Chorioamnionitis; Cervical Length; Amniocentesis
Citation: Clemente-Tomás CP and Moreno-Sanz L. “Usefulness of the Determination of Interleukin-6 (IL-6) in Amniotic Fluid in Women at Risk of Preterm Birth”.Acta Scientific Medical Sciences 7.8 (2023): 84-86.
Copyright: © 2023 Clemente-Tomás CP and Moreno-Sanz L. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.